May 22, 2015 article Open access CCL2-CCR2 Signaling in Disease Pathogenesis Endocrine Metabolic & Immune Disorders - Drug Targets DOI: 10.2174/1871530315666150316120920 Full text (OA) OpenAlex Authors 0 Author list not loaded yet. Cited by 3 stored of 170 Search Sort Most cited Newest Oldest Patent citations Title Any typearticle review book-chapter conference-paper preprint dissertation book dataset other Any fieldAgricultural and Biological Sciences Arts and Humanities Biochemistry, Genetics and Molecular Biology Business, Management and Accounting Chemical Engineering Chemistry Computer Science Decision Sciences Dentistry Earth and Planetary Sciences Economics, Econometrics and Finance Energy Engineering Environmental Science Health Professions Immunology and Microbiology Materials Science Mathematics Medicine Neuroscience Nursing Pharmacology, Toxicology and Pharmaceutics Physics and Astronomy Psychology Social Sciences Veterinary Open access Leveraging Targeted Protein Degradation for G Protein-Coupled Receptors: The Development of CCR2 Molecular Degraders 2025 Journal of Medicinal Chemistry article Biochemistry, Genetics and Molecular Biology Protein Degradation and Inhibitors Open access 2 citations PCSK9 Imperceptibly Affects Chemokine Receptor Expression In Vitro and In Vivo 2021 International Journal of Molecular Sciences article Immunology and Microbiology Atherosclerosis and Cardiovascular Diseases Open access 6 citations Design and Characterization of an Intracellular Covalent Ligand for CC Chemokine Receptor 2 2021 Journal of Medicinal Chemistry article Medicine Chemokine receptors and signaling Open access cited by 3 patents 32 citations 3 results Cited by imported patents 1 (EPO, DOI in their cited literature) PROTAC COMPOUNDS 2025 WO2025216628A1 Chemistry & metallurgy 1 office References 0